RANKINGS

POPULAR STOCKS

Level Biotechnology Inc.

Taipei Exchange:3118.TWO

Location

Taiwan

Market Cap

USD 35.26 M

Share Price

USD 1.09

Avg Daily Volume

28,504

Change (1 day)

-0.15%

Change (1 year)

Change (YTD)

5.93%

Level Biotechnology Inc. Price to Book Ratio (P/B) on June 19, 2025: 2.07

Level Biotechnology Inc. Price to Book Ratio (P/B) is 2.07 on June 19, 2025. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Level Biotechnology Inc. 52-week low Price to Book Ratio (P/B) is 2.17 on June 19, 2025, which is 5.17% above the current Price to Book Ratio (P/B).
  • Level Biotechnology Inc. 52-week low Price to Book Ratio (P/B) is 1.75 on June 19, 2025, which is -15.21% below the current Price to Book Ratio (P/B).
  • Level Biotechnology Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 2.00.
Key data
Date Price to Book Ratio (P/B) Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield
Market news
Taipei Exchange: 3118.TWO

Level Biotechnology Inc.

CEO Yihan Li
IPO Date Aug. 20, 2008
Location Taiwan
Headquarters No. 80, Kangning Street
Employees 132
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
💊 Pharmaceuticals
Description

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

StockViz Staff

June 20, 2025

Any question? Send us an email